| Supriya Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543434 |
NSE Symbol : SUPRIYA |
P/E(TTM) : 37.23 |
|
ISIN Demat : INE07RO01027 |
Div & Yield% : 0.11 |
EPS(TTM) : 19.57 |
|
Book Value(₹) : 112.56 |
Market Cap(₹Cr) : 5,864.38 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 166.10 | 160.63 | 158.18 | 140.07 | 140.10 | 132.02 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 166.10 | 160.63 | 158.18 | 140.07 | 140.10 | 132.02 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.52 | 2.22 | 2.19 | 3.07 | 2.47 | 2.92 |
| Total Income | 168.62 | 162.85 | 160.37 | 143.14 | 142.56 | 134.94 |
| Total Expenditure | 101.39 | 98.09 | 102.68 | 98.59 | 108.34 | 87.79 |
| PBIDT | 67.24 | 64.77 | 57.69 | 44.55 | 34.22 | 47.15 |
| Interest | 0.43 | 0.34 | 0.60 | 0.49 | 0.46 | 0.56 |
| PBDT | 66.81 | 64.43 | 57.09 | 44.06 | 33.76 | 46.59 |
| Depreciation | 4.74 | 4.66 | 3.91 | 3.96 | 3.98 | 3.96 |
| Tax | 15.45 | 14.67 | 8.94 | 9.66 | 8.54 | 9.96 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.47 | 0.46 | 7.30 | 0.66 | -2.64 | 4.16 |
| Reported Profit After Tax | 46.15 | 44.64 | 36.93 | 29.79 | 23.88 | 28.51 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 46.15 | 44.64 | 36.93 | 29.79 | 23.88 | 28.51 |
| EPS (Unit Curr.) | 5.71 | 5.54 | 4.59 | 3.70 | 2.97 | 3.54 |
| EPS (Adj) (Unit Curr.) | 5.71 | 5.54 | 4.59 | 3.70 | 2.97 | 3.54 |
| Calculated EPS (Unit Curr.) | 5.73 | 5.55 | 4.59 | 3.70 | 2.97 | 3.54 |
| Calculated EPS (Adj) (Unit Curr.) | 5.73 | 5.55 | 4.59 | 3.70 | 2.97 | 3.54 |
| Calculated EPS (Ann.) (Unit Curr.) | 22.94 | 22.19 | 18.35 | 14.80 | 11.87 | 14.17 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 22.94 | 22.19 | 18.35 | 14.80 | 11.87 | 14.17 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.10 | 16.10 | 16.10 | 16.10 | 16.10 | 16.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 40.48 | 40.32 | 36.47 | 31.81 | 24.43 | 35.71 |
| PBDTM(%) | 40.22 | 40.11 | 36.09 | 31.46 | 24.10 | 35.29 |
| PATM(%) | 27.78 | 27.79 | 23.35 | 21.27 | 17.04 | 21.60 |